Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines
- 1 February 1999
- Vol. 17 (7-8) , 832-836
- https://doi.org/10.1016/s0264-410x(98)00267-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Induction of measles virus‐specific cytotoxic T‐cell responses after intranasal immunization with synthetic peptidesImmunology, 1996
- Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomesVaccine, 1995
- Evidence that the amino acid region 124–203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infectionAntiviral Research, 1995
- Induction of systemic immune responses to measles virus synthetic peptides administered intranasallyVaccine, 1995
- Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa infection in a murine acute pneumonia modelVaccine, 1995
- Selective induction of protection against influenza virus infection in mice by a lipid—peptide conjugate delivered in liposomesVaccine, 1994
- Cellular Communication Networks Implications for Our Understanding of Gastrointestinal PhysiologyAnnals of the New York Academy of Sciences, 1992
- Neutralization of cholera toxin by rat IgA secretory antibodies induced by a free synthetic peptideBiochemical and Biophysical Research Communications, 1989
- Oral immunization with a free peptide from cholera toxin: Local protection and IgA productionMolecular Immunology, 1989
- Manipulation of antipeptide immune response by varying the coupling of the peptide with the carrier proteinMolecular Immunology, 1989